Testing is underway on vaccines to intercept brewing colon cancer before it takes root

Dr. Stacy Norton lost her mother to colon cancer when she was just seven years old. As an adult, the Houston physician discovered she carried Lynch syndrome, a genetic mutation that turns the body’s internal 'spellchecker' for DNA off, leaving carriers at a massive risk for aggressive tumors.

Now, Norton is among the first to test a medical breakthrough that could change the lives of her children and millions of others. Scientists are developing vaccines that don't fight viruses, but instead teach the immune system to intercept brewing cancers before they become life-threatening.

Targeting the Genetic Glitch

Lynch syndrome affects roughly 1 in 279 people, often leading to colorectal, uterine, and pancreatic cancers well before the age of 50. While the average person faces a 5% lifetime risk of colon cancer, those with this faulty gene face odds as high as 80%.

Because Lynch-related growths produce unique proteins not found in healthy cells, researchers can 'train' the immune system to recognize these abnormalities. The goal is to create a biological search-and-destroy mission that clears out polyps before they turn malignant.

Promising Trial Results

In a recent study involving Norton and 44 other participants, a vaccine developed by Swiss biotech firm Nouscom showed significant promise. One year after receiving the shots, colonoscopies revealed fewer precancerous growths and zero advanced polyps among the group.

"It gives me hope," Norton said, noting that her own recent screenings have been entirely clear. She hopes the technology will eventually mean her adult children won't have to endure invasive annual colonoscopies for the rest of their lives.

The Global Race for a Cure

The fight is expanding globally, with Oxford University researchers beginning tests on an mRNA-based vaccine developed by Moderna. Meanwhile, California’s ImmunityBio is awaiting results from a trial of its own version, the Tri-Ad5 vaccine.

As colorectal cancer cases rise among younger adults, experts urge families with a history of early-onset tumors to seek genetic testing. Knowing your status can lead to life-saving preventive measures, even as these new vaccines move closer to a wider rollout.